Aller au contenu principal
Profil bibliographique

Hongyu Xiang

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

23Publications signalées
264Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Financial Literacy, Pension, Retirement AnalysisSpeech Recognition and SynthesisCorporate Finance and GovernanceBreast Cancer Treatment StudiesHousing Market and Economics

Les publications récentes

Accès ouvert 2025 article OpenAlex

The shared consumption paradox: Financial scarcity hinders shared consumption

Xiaomin Liu, Xue Wang, Hongyu Xiang, Song Su

摘要: 基于资源稀缺的自我调节模型, 本文探索了财务稀缺心态对共享消费的影响及其内在机制。通过6项研究发现, 尽管共享消费具有单次花费低、效用多样化的优势, 能够为财务稀缺个体带来诸多益处, 但是具有财务稀缺心态的个体更不愿意参与共享消费, 我们将这一现象称为“共享消费悖论”。进一步研究发现, 财务稀缺心态主要激活控制恢复路径, 增强消费者对商品的心理所有权需求, 从而阻碍共享消费。本文还发现“强调产品归属性”可以消除财务稀缺心态对共享消费的负面影响, 以及当共享产品的价格优势凸显或个体作为共享物品的提供者时, 这种负面影响也会被削弱。

cn (code pays fourni par la source)

0 citations Acta Psychologica Sinica
Accès ouvert 2023 article OpenAlex

A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression

Ling Xin, Qian Wu, Chongming Zhan, Hongyan Qin et autres

BACKGROUND: In light of the significant clinical benefits of antibody-drug conjugates in clinical trials, the human epidermal growth factor receptor 2 (HER2)-low category in breast cancers has gained increasing attention. Therefore, we studied the clinicopathological characteristics of Chinese patients with hormone receptor …

cn (code pays fourni par la source)

2 citations Chinese Medical Journal
Accès ouvert 2023 article OpenAlex

Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period

Mao Ding, Hongyu Xiang, Jingming Ye, Yuanjia Cheng et autres

Background: COVID-19 is an acute infectious disease caused by SARS-CoV-2. The best time to restart antitumor therapy in breast cancer patients after SARS-CoV-2 infection is unknown. This study aimed to evaluate treatment-related adverse events in breast cancer patients who received antitumor therapies …

cn (code pays fourni par la source)

2 citations Frontiers in Oncology
Accès ouvert 2022 article OpenAlex

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)

Yuanjia Cheng, Hongyu Xiang, Ling Xin, Xuening Duan et autres

BACKGROUND: Pertuzumab has been approved for application in China by the National Medical Products Administration, and both national and international guidelines make recommendations for the use of neoadjuvant treatment with trastuzumab or trastuzumab + pertuzumab plus chemotherapy regimens for patients with indications. …

cn (code pays fourni par la source)

3 citations Chinese Medical Journal
Accès ouvert 2021 article OpenAlex

Introduction to the key contents of the Chinese Society of Breast Surgery Practice Guideline 2021

Hongyu Xiang, Qian Liu, Yinhua Liu

Breast disease is one of the most common afflictions for women worldwide. While clinical diagnosis and treatments have progressed rapidly in recent years, surgical procedures are still a mainstay of treatment for breast diseases. The Chinese Society of Breast Surgery (CSBrS) Practice …

cn (code pays fourni par la source)

0 citations Translational Breast Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.